On the public citation graph
Synthetic Activators of Cell Migration Designed by Constructive Machine Learning
0 signed · 57 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ange.201706376openalex-snapshot
A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds
inferredcites →https://doi.org/10.1002/ange.201814681openalex-snapshot
Automated De Novo Drug Design: Are We Nearly There Yet?
inferredcites →https://doi.org/10.1002/anie.201706376openalex-snapshot
A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds
inferredcites →https://doi.org/10.1002/anie.201814681openalex-snapshot
Automated De Novo Drug Design: Are We Nearly There Yet?
inferredcites →https://doi.org/10.1002/minf.201200141openalex-snapshot
Chemically Advanced Template Search (CATS) for Scaffold‐Hopping and Prospective Target Prediction for ‘Orphan’ Molecules
inferredcites →https://doi.org/10.1002/minf.201700111openalex-snapshot
Generative Recurrent Networks for De Novo Drug Design
inferredcites →https://doi.org/10.1002/minf.201700153openalex-snapshot
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
inferredcites →https://doi.org/10.1002/open.201900222openalex-snapshot
Synthetic Activators of Cell Migration Designed by Constructive Machine Learning
inferredcites →https://doi.org/10.1016/j.bcp.2008.12.014openalex-snapshot
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
inferredcites →https://doi.org/10.1016/j.bmc.2014.07.004openalex-snapshot
Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
inferredcites →https://doi.org/10.1016/j.bmcl.2010.03.118openalex-snapshot
Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity
inferredcites →https://doi.org/10.1016/j.bmcl.2010.11.023openalex-snapshot
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication
inferredcites →https://doi.org/10.1016/j.bmcl.2011.01.021openalex-snapshot
Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
inferredcites →https://doi.org/10.1016/j.bmcl.2015.04.036openalex-snapshot
Discovery of novel N-aryl piperazine CXCR4 antagonists
inferredcites →https://doi.org/10.1016/j.ejmech.2016.02.051openalex-snapshot
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities
inferredcites →https://doi.org/10.1016/j.intimp.2016.07.002openalex-snapshot
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway
inferredcites →https://doi.org/10.1016/j.semcancer.2008.10.001openalex-snapshot
Chemokine signaling in cancer: One hump or two?
inferredcites →https://doi.org/10.1016/s0167-5699(99)01469-3openalex-snapshot
The chemokine system: redundancy for robust outputs
inferredcites →https://doi.org/10.1021/acs.jcim.5b00181openalex-snapshot
Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b00216openalex-snapshot
Development of Novel CXC Chemokine Receptor 7 (CXCR7) Ligands: Selectivity Switch from CXCR4 Antagonists with a Cyclic Pentapeptide Scaffold
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b00987openalex-snapshot
Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)
inferredcites →https://doi.org/10.1021/acscentsci.7b00512openalex-snapshot
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
inferredcites →https://doi.org/10.1021/jm100073mopenalex-snapshot
Discovery of Novel Small Molecule Orally Bioavailable C−X−C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication
inferredcites →https://doi.org/10.1021/jm801065qopenalex-snapshot
Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo
inferredcites →https://doi.org/10.1021/jm9602928openalex-snapshot
The Properties of Known Drugs. 1. Molecular Frameworks
inferredcites →https://doi.org/10.1021/ml400183qopenalex-snapshot
Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists
inferredcites →https://doi.org/10.1038/75556openalex-snapshot
Gene Ontology: tool for the unification of biology
inferredcites →https://doi.org/10.1038/s42004-018-0068-1openalex-snapshot
Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators
inferredcites →https://doi.org/10.1038/s42256-019-0030-7openalex-snapshot
Mind and machine in drug design
inferredcites →https://doi.org/10.1038/srep15338openalex-snapshot
Computer-assisted quantification of motile and invasive capabilities of cancer cells
inferredcites →https://doi.org/10.1073/pnas.1120431109openalex-snapshot
Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4
inferredcites →https://doi.org/10.1073/pnas.1320001111openalex-snapshot
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
inferredcites →https://doi.org/10.1073/pnas.95.16.9448openalex-snapshot
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
inferredcites →https://doi.org/10.1074/jbc.m204667200openalex-snapshot
Identification of Allosteric Peptide Agonists of CXCR4
inferredcites →https://doi.org/10.1080/17460441.2017.1274727openalex-snapshot
Macromolecular target prediction by self-organizing feature maps
inferredcites →https://doi.org/10.1093/nar/gkr777openalex-snapshot
ChEMBL: a large-scale bioactivity database for drug discovery
inferredcites →https://doi.org/10.1093/nar/gkt1031openalex-snapshot
The ChEMBL bioactivity database: an update
inferredcites →https://doi.org/10.1093/nar/gkw1108openalex-snapshot
Expansion of the Gene Ontology knowledgebase and resources
inferredcites →https://doi.org/10.1128/aac.04654-14openalex-snapshot
Insights into the Mechanism of Inhibition of CXCR4: Identification of Piperidinylethanamine Analogs as Anti-HIV-1 Inhibitors
inferredcites →https://doi.org/10.1146/annurev.iy.12.040194.003113openalex-snapshot
The Molecular Biology of Leukocyte Chemoattractant Receptors
inferredcites →https://doi.org/10.1182/blood-2005-08-3182openalex-snapshot
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
inferredcites →https://doi.org/10.1182/blood-2008-12-196618openalex-snapshot
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
inferredcites →https://doi.org/10.1186/s13321-017-0235-xopenalex-snapshot
Molecular de-novo design through deep reinforcement learning
inferredcites →https://doi.org/10.3390/molecules23102520openalex-snapshot
Artificial Intelligence in Drug Design
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cssc.202201075openalex-snapshot
Effective Ligand Design: Zinc Complexes with Guanidine Hydroquinoline Ligands for Fast Lactide Polymerization and Chemical Recycling
inferred← citeshttps://doi.org/10.1002/minf.202000109openalex-snapshot
Virtual Screening and Design with Machine Intelligence Applied to Pim‐1 Kinase Inhibitors
inferred← citeshttps://doi.org/10.1002/trc2.12445openalex-snapshot
Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105403openalex-snapshot
Generative machine learning for de novo drug discovery: A systematic review
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c01345openalex-snapshot
Exploration of Chemical Space Guided by PixelCNN for Fragment-Based De Novo Drug Discovery
inferred← citeshttps://doi.org/10.1038/s41573-019-0050-3openalex-snapshot
Rethinking drug design in the artificial intelligence era
inferred← citeshttps://doi.org/10.1038/s41598-022-11879-1openalex-snapshot
Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection
inferred← citeshttps://doi.org/10.1126/sciadv.abg3338openalex-snapshot
Combining generative artificial intelligence and on-chip synthesis for de novo drug design
inferred← citeshttps://doi.org/10.26434/chemrxiv.13498587openalex-snapshot
Combining Generative Artificial Intelligence and On-Chip Synthesis for De Novo Drug Design
inferred← citeshttps://doi.org/10.2751/jcac.23.1openalex-snapshot
Critical Assessment of Generative Models for de Novo Molecular Structure Generation
inferred← citeshttps://doi.org/10.5023/jappstat.52.75openalex-snapshot
Application of Deep Learning in Materials Design: Extraction of Process-Structure-Property Relationship
showing the first 11 of 12 · page through all 12
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.